US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biomarkers Market Research Reports & Industry Analysis

The high specificity required of biomarkers in research, drug development and clinical diagnostics creates significant diversity in the global biomarkers market. The greatest focus in biomarkers development is oncology with cancer biomarkers occupying the largest space at over 25% of the market. Biomarkers are parameters or analytes integral to or associated with a biochemical, anatomical, pathogenic, pharmacologic or molecular (genetic) process of clinical interest.

Biomarker discovery continues to power the development of in vitro diagnostic (IVD) tests used to diagnose disease and health conditions, predict patient response to therapy, and monitor therapeutic effects and patient health. Ideal biomarkers have excellent sensitivity and specificity in terms of identifying disease, determining disease state, or evaluating patient response to therapy. Biomarkers are generally proteins (products of gene expression) or nucleic acid sequences (either RNA or DNA); small molecules that are products of metabolism may also serve as biomarkers.

The proliferation of biomarkers is a result of greater clinical understanding of the interconnections between genetics, proteomics and gene expression, disease susceptibility, disease manifestation, and disease susceptibility to select therapies. Biomarkers can be classified as natural history markers (allow for the detection and isolation of a particular cell type), drug activity markers (indicate patient response to pharmological intervention), or surrogate markers (markers that can be used as an alternative to traditional endpoints such as morbidity and mortality to evaluate the effectiveness of a therapy in treating disease). Genomic research is expected to further expand the availability of biomarkers for various diseases and make significant contributions to personalized medicine.

In addition to cancer biomarkers, biomarkers are also available for cardiac function and episodes, other cardiovascular conditions, coagulation or hemostasis, endocrine function, blood sugar management, autoimmune disorders, inflammation, specific infectious diseases, sepsis, and neurological disorders. Over half of the biomarkers market exists in clinical applications, the rest in drug development, research and clinical trial applications. Biomarkers are broadly used for disease risk assessment, diagnosis, screening, treatment or therapy selection, and therapeutic monitoring.

RSS Feeds

Biomarkers Industry Research & Market Reports

< prev 1    3  4  5  6  
Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies)
9/4/2014 | published by: Kalorama Information
... proteins. This includes the study of which proteins are expressed, when and where they are expressed, structure of proteins, roles of proteins, and interactions of proteins. Proteomics is a large field that has focused on ...  |  read more...
USD 4,200
Companion Diagnostics Market
8/8/2014 | published by: Kalorama Information
... with several of them part of a routine diagnostic and treatment plan. This report tracks these developments and provides detailed examples of drug-test pairs.  It also provides market estimation and forecast models for business planning. ...  |  read more...
USD 3,995
miRNA Research and Diagnostics Markets
9/4/2014 | published by: Kalorama Information
... the post-transcriptional level. These small bits of RNA, members of a class of non-translated molecules that do not produce protein, shut off gene transcription by base pairing with the target molecules.  They are now recognized as ...  |  read more...
USD 2,995
USD 19,700
USD 6,100
USD 6,100
Human Microbiome Market by Disease (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder), Application (Therapeutic, Diagnostic) & by Product (Probiotic, Prebiotic, Food, Medical Food, Supplement, Device, Drug) – Global Forecast to 2023
9/10/2014 | published by: MarketsandMarkets
... diagnosis and efficient treatment with microbiome therapy for maintaining healthy lifestyle will boost the human microbiome market The product segment is expected to account for the largest share of the human microbiome market in the ...  |  read more...
USD 4,650
POCT Market in China : 2014-2018
9/10/2014 | published by: TechNavio - Infiniti Research Ltd.
... is gaining popularity due to the increasing incidence and prevalence of lifestyle diseases such as diabetes, heart disease, and obesity. It is generally cost-effective and user-friendly. POCT devices are standardized to minimize errors during the ...  |  read more...
USD 2,500
USD 6,100
USD 3,850
USD 3,850
USD 4,850
USD 3,850
USD 3,850
Biomarkers in Alzheimer's Disease
8/1/2014 | published by: CHI Insight Pharma Reports
... Disorders, this report focuses on the Alzheimer’s Disease space featured in the parent report, highlighting several biomarker targets under investigation and the progress that has been made in the industry. With regards to employing the ...  |  read more...
USD 699
MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets
9/1/2014 | published by: BCC Research
... $572 million in 2014 and $1 billion in 2019, at a compound annual growth rate (CAGR) of 12.6% for the period of 2014 to 2019. This report provides: An overview of the global market for ...  |  read more...
USD 6,650
Future Horizons and Growth Strategies in the US Hospital Tumor Marker Testing Market 2014: Supplier Shares and Country Forecasts
8/28/2014 | published by: Venture Planning Group
... comprehensive analysis of the US hospital tumor market testing market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during ...  |  read more...
USD 6,500
Autoimmune Disease Diagnostics: Global Markets
9/1/2014 | published by: BCC Research
... 2019, with a compound annual growth rate (CAGR) of 1.6% for the five-year period, 2014 to 2019. This report provides: An overview of the global market for autoimmune disease diagnostics. Analyses of global market trends, ...  |  read more...
USD 6,650
USD 32,500
USD 7,500
USD 6,100
USD 6,100
USD 9,700
USD 3,850
Biomarker Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. ...  |  read more...
USD 1,495
< prev 1    3  4  5  6